Delivery Order SPE2DB22D2005-SPE2DB25FJEC5

Award Date 10/28/24
Potential Completion Date 10/29/24
Potential Value $2.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,611.60, is for the delivery of 4567117520 - Lidocaine 2% Viscous 15 ML Cup UD 15ML, a pharmaceutical product, to support military healthcare programs. The order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of 4,564,313,846 units of Lidocaine 2% Viscous 15 ML Cup. The contract has a firm-fixed price of $1,175.73 and a completion date of April 18, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lidocaine 2% Viscous 15 ML Cup UD 15ML, a pharmaceutical product. The contract has a firm fixed price and a ceiling value of $1,684.84. It is not a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award, valued at $2,419.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lidocaine 2% Viscous Solution, a pharmaceutical product, to support military and federal healthcare programs. The contract has an ultimate completion date of November 17, 2023, and is a Firm Fixed Price Delivery Order. The award is associated with a larger...
This federal contract award, valued at $1,070.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567130613 - Lidocaine 2% Viscous Solution 100ML, a medical product used in various healthcare settings. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of February 4, 2025. It is not designated as a...
This federal contract award, with a ceiling value of $2,042.26, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a for-profit pharmaceutical sourcing and distribution company. The contract is a firm fixed price delivery order for the supply of 4564240352 - Lidocaine 2% Viscous 15 ML Cup UD 15ML, with a period of performance through April 12, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, with a...
This contract award is for the delivery of 15 ml cups of 2% lidocaine viscous solution to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $1,829.68, was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company that supplies a wide range of medical products to federal agencies. The contract is a delivery order issued under Amerisourcebergen's existing Indefinite Delivery...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $1,849.16 firm fixed price contract is for the delivery of 100 ml bottles of 2% lidocaine viscous solution to support military treatment programs and facilities. The delivery order does not have a set-aside designation and is being issued under...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 15 ml cups of 2% Lidocaine Viscous, a local anesthetic medication. The award has a ceiling value of $1,704.23 and a completion date of May 19, 2025. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen Drug...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of Lidocaine 2% Viscous Solution 100ML, a pharmaceutical product, to support military treatment programs and facilities. The contract is a firm fixed-price arrangement with a ceiling value of $1,037.48 and a performance period through March 11, 2024. Amerisourcebergen Drug...
  • SPE2DB22D2005
    Indefinite Delivery Contract
  • SPE2DB22D2005-SPE2DB25FJEC5
    Delivery Order

This federal contract award, identified as SPE2DB22D2005|SPE2DB25FJEC5, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $2,269.72, is for the delivery of Lidocaine 2% Viscous 15 ML CUP UD 15ML, a medical product used in various healthcare settings.

The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition.

Generated 5/20/25, 2:05 PM